S. Jalaja, Secretary, Dept of AYUSH, set the scene, explaining difficulties encountered by Ayurvedic product manufacturers in meeting onerous standards set by the Directive. Although it was passed in 2004, with a 7 year transition phase, no Ayurvedic herbal medicine has yet been registered even under its simplified licensing regime. Harsha Gramminger, president of EUAA and long-time Ayurveda practitioner, commented that a broad crosssection of interests was finally coming together to help protect the multi-faceted and holistic system of Ayurveda, which potentially holds so many answers to the burden of chronic disease afflicting modern healthcare systems.
Strategies were coordinated in four fields: Lobbying, Legal challenges, Scientific Advice and Policy approaches. Close cooperation emerged between European and Indian governmental and non-governmental bodies. In particular, a core group concerned with ways to preserve patient's choice of Ayurvedic treatments under Erika Mann, has already started coordinating various activities.
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